RECRUITING

GYNecologic Cancer-Related COGnitive Impairment

Description

The goal of this study is to test a home-based and patient-tailored cognitive training intervention among gynecologic cancer patients who have completed chemotherapy and who have experienced cancer-related cognitive impairment.

Conditions

Ovarian CancerEndometrial CancerCervical CancersVulvar CancersUterine CancerCervix CancerOvary Cancer
Talk to us

Related Conditions:

Ovarian CancerEndometrial CancerCervical CancersVulvar CancersUterine CancerCervix CancerOvary Cancer

Study Overview

On this page

Study Details

Study overview

The goal of this study is to test a home-based and patient-tailored cognitive training intervention among gynecologic cancer patients who have completed chemotherapy and who have experienced cancer-related cognitive impairment.

A Pilot and Mixed-Methods Study of GYNecologic Cancer-Related COGnitive Impairment

GYNecologic Cancer-Related COGnitive Impairment

Condition
Ovarian Cancer
Intervention / Treatment

-

Contacts and Locations

Chicago

Northwestern University, Chicago, Illinois, United States, 60611

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * Female; ≥18 years of age
  • * Presents to clinic with a confirmed diagnosis of a gynecologic cancer (e.g., ovarian, endometrial, cervical, or vulvar cancer) who have completed adjuvant chemotherapy with at least stable disease at time of screening.
  • * Screen positive for subjective cognitive impairment by answering affirmatively to at least one of three screener questions
  • * Fluent in spoken and written English
  • * Have access to the internet to complete assessments
  • * Patients who have not received chemotherapy
  • * Patients with pre-existing neuropsychiatric disorders that would impact cognitive function, such as dementia, Alzheimer's disease, and schizophrenia.
  • * Patients with non-gynecologic causes of incurable metastatic cancers.
  • * Patients undergoing active interventions in other cognitive trials or patients currently using cognitive training programs such as Brain HQ, Luminosity, Elevate, Peak, Fit Brains, or CogniFit.
  • * Patients with self-report of learning disability or an unwillingness to participate in technology-based cognitive training programs.
  • * Pregnant women or prisoners
  • * Patients with impaired-decision making capacity

Ages Eligible for Study

18 Years to

Sexes Eligible for Study

FEMALE

Accepts Healthy Volunteers

No

Collaborators and Investigators

Northwestern University,

Emma Barber, MD, MS, PRINCIPAL_INVESTIGATOR, Northwestern University

Study Record Dates

2028-12